InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Zymeworks Inc.

ZYME Clue Score44
United States Fiscal year ends December CIK 0001937653
$25.79 +2.10% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $25.79 +0.51% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 28 Apr 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue39.0Operating income−187.5Net income−180.6EPS, diluted−3.58Fiscal year 2021Revenue26.7 −31.5%Operating income−215.6Net income−211.8EPS, diluted−4.61Fiscal year 2022Revenue412.5 +1,446.0%Operating income130.5Net income124.3EPS, diluted1.90Fiscal year 2023Revenue76.0 −81.6%Operating income−138.1Net income−118.7 −195.4%EPS, diluted−1.72 −190.5%Fiscal year 2024Revenue76.3 +0.4%Operating income−137.1Net income−122.7EPS, diluted−1.62Fiscal year 2025Revenue106.0 +38.9%Operating income−92.5Net income−81.1EPS, diluted−1.08
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 39.0 26.7 412.5 76.0 76.3 106.0
Growth −31.5% +1,446.0% −81.6% +0.4% +38.9%
Operating income −187.5 −215.6 130.5 −138.1 −137.1 −92.5
Net income −180.6 −211.8 124.3 −118.7 −122.7 −81.1
Growth −195.4%
EPS, diluted −3.58 −4.61 1.90 −1.72 −1.62 −1.08
Growth −190.5%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Operating margin−481.3%Net margin−463.5%Free cash flow margin−399.8%Fiscal year 2021Operating margin−808.2%Net margin−794.0%Free cash flow margin−767.8%Fiscal year 2022Operating margin31.6%Net margin30.1%Free cash flow margin33.0%Fiscal year 2023Operating margin−181.6%Net margin−156.1%Free cash flow margin−158.9%Fiscal year 2024Operating margin−179.7%Net margin−160.8%Free cash flow margin−146.8%Fiscal year 2025Operating margin−87.3%Net margin−76.6%Free cash flow margin−32.6%
FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −481.3% −808.2% 31.6% −181.6% −179.7% −87.3%
Net margin −463.5% −794.0% 30.1% −156.1% −160.8% −76.6%
Free cash flow margin −399.8% −767.8% 33.0% −158.9% −146.8% −32.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−151.4Capital expenditure−4.3Free cash flow−155.7Fiscal year 2021Operating cash flow−192.5Capital expenditure−12.4Free cash flow−204.9Fiscal year 2022Operating cash flow144.1Capital expenditure−8.2Free cash flow136.0Buybacks0.0Fiscal year 2023Operating cash flow−118.3Capital expenditure−2.5Free cash flow−120.8 −188.8%Buybacks0.0Fiscal year 2024Operating cash flow−110.1Capital expenditure−2.0Free cash flow−112.0Buybacks−30.1Fiscal year 2025Operating cash flow−33.0Capital expenditure−1.5Free cash flow−34.5Buybacks−41.7
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −151.4 −192.5 144.1 −118.3 −110.1 −33.0
Capital expenditure −4.3 −12.4 −8.2 −2.5 −2.0 −1.5
Free cash flow −155.7 −204.9 136.0 −120.8 −112.0 −34.5
Growth −188.8%
Buybacks n/a n/a 0.0 0.0 −30.1 −41.7

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash242.0Shareholders’ equity409.9Fiscal year 2021Cash201.9Shareholders’ equity249.1Fiscal year 2022Cash400.9Shareholders’ equity493.0Fiscal year 2023Cash157.6Shareholders’ equity464.8Fiscal year 2024Cash66.1Shareholders’ equity338.8Fiscal year 2025Cash41.2Shareholders’ equity268.5
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 242.0 201.9 400.9 157.6 66.1 41.2
Shareholders’ equity 409.9 249.1 493.0 464.8 338.8 268.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
39.0 26.7 412.5 76.0 76.3 106.0
Growth −31.5% +1,446.0% −81.6% +0.4% +38.9%
171.2 199.8 208.6 143.6 n/a n/a
55.2 42.6 73.4 70.4 61.5 61.5
−187.5 −215.6 130.5 −138.1 −137.1 −92.5
Growth −205.8%
−180.1 −212.4 135.2 −119.2 −116.6 −79.8
0.4 −0.5 10.9 −0.6 6.1 1.4
−180.6 −211.8 124.3 −118.7 −122.7 −81.1
Growth −195.4%
Per share
−3.58 −4.11 1.91 −1.72 −1.62 −1.08
−3.58 −4.61 1.90 −1.72 −1.62 −1.08
Growth −190.5%
50.4 51.6 65.2 68.9 75.8 75.4
50.4 52.1 65.2 68.9 75.9 75.4
Growth +3.5% +25.2% +5.5% +10.2% −0.6%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 22.2% a year over five years.
  • The diluted share count rose 49.7% in five years, which is dilution.
  • Operating margin is up 394.0 points on five years ago, at -87.3%.
  • A net loss in 5 of 6 years on file.